1 Feb 2012 15:16
Immunodiagnostic Systems Holdings plc
Appointment of Nominated Adviser and Broker
Immunodiagnostic Systems Holdings plc (the "Company") announces that, as a result of the completion of the transfer of the business of the Corporate Advisory & Broking division of Brewin Dolphin Limited to Nplus1 Brewin LLP ("N+1 Brewin"), with effect from today, N+1 Brewin has been appointed as the Company's Nominated Adviser and Broker.
For further information, please contact:
Immunodiagnostic Systems Holdings plc Ian Cookson, Chief Executive Officer Paul Hailes, Finance Director
| Tel: 0191 519 0660 |
N+1 Brewin (Nominated Adviser & Broker) Aubrey Powell/ Luke Boyce
| Tel: 020 3201 3710 |
Walbrook PR Ltd Paul McManus Fiona Henson
| Tel: 020 7933 8780 Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com Mob: 07886 335 992 or fiona.henson@walbrookpr.com |
END